Geneyx Genomex Ltd., a global provider of genomic analysis and interpretation solutions, has announced its approval as a supplier on the UK Government’s G-Cloud 15 framework. This new listing provides eligible UK public-sector organizations, including NHS organizations, public-sector genomic laboratories, and research institutions, with a streamlined procurement route to Geneyx’s cloud-based genomic analysis and interpretation software.
The company’s platform combines AI-powered agentic workflows, long- and short-read analysis, and multi-omics integration across DNA, RNA, and epigenetic data. This innovative approach is particularly relevant as genomic laboratories face increasing volumes and complexity of sequencing data from a variety of technologies.
David Yizhar, CEO of Geneyx Genomex Ltd., stated, “Joining G-Cloud 15 is an important step in expanding access to Geneyx across the UK. Our inclusion on G-Cloud 15 gives eligible UK organizations a more straightforward procurement route to our AI-powered agentic workflows, long-read capabilities, and integrated multi-omics analysis. This will help laboratories move from complex sequencing data towards prioritized, interpretable findings more efficiently.”
Geneyx’s platform supports genomic analysis and interpretation across rare and inherited diseases and oncology. Its multi-omics capabilities enable DNA, RNA, and epigenetic information to be analyzed within an integrated workflow, helping researchers and genomic specialists investigate findings that may not be fully resolved by a single data type alone.
The company currently serves more than 5,500 users in 55 countries and has performed over 694,000 genomic analyses on its platform. Geneyx is committed to accelerating the adoption of genomic medicine and precision healthcare through collaborations with leading sequencing, technology, and healthcare organizations.
G-Cloud 15 is the latest generation of the UK Government’s framework for procuring cloud-based computing services, including cloud software, hosting, and support. It provides public-sector organizations with access to approved cloud suppliers and offers a quick and easy route to market.
For more information about Geneyx’s G-Cloud 15 supplier listing, visit https://www.applytosupply.digitalmarketplace.service.gov.uk/g-cloud-15/supplier/723633.
To learn more about G-Cloud 15, visit https://www.gca.gov.uk/agreements/RM1557.15.
About Geneyx Genomex Ltd.
Geneyx is a global digital health company focused on redefining clinical genomics through AI-driven, high-throughput next-generation sequencing analysis and interpretation. Its scalable platform supports rapid, accurate, and cost-effective genomic interpretation across rare and inherited diseases and oncology by combining AI-powered analysis with short- and long-read sequencing and multi-omics capabilities.
The company serves more than 5,500 users in 55 countries, with over 694,000 genomic analyses performed on its platform to date. Geneyx supports healthcare institutions, research centers, and national genomic programs worldwide and is working with leading sequencing, technology, and healthcare organizations to accelerate the adoption of genomic medicine and precision healthcare.
To learn more, visit www.geneyx.com.
Media contact:
Dr. Suzie Drury
Product Manager
email: suzie@geneyx.com
Phone: +447800533005
